Structure of the azurin mutant Phe114Ala from<i>Pseudomonas aeruginosa</i>at 2.6 Å resolution

L.‐C. Tsai(Chalmers University of Technology), Herbert Nar(Boehringer Ingelheim (Germany)), V. Langer, T. Sjölin, T. Pascher

Acta Crystallographica Section D Biological Crystallography

March 1, 1995

10.1107/s0907444994005627

Cited by 17

Related Papers

A specific antidote for dabigatran: functional and structural characterization

|Blood|2013|562

Crystal structure analysis of oxidized Pseudomonas aeruginosa azurin at pH 5·5 and pH 9·0

|Journal of Molecular Biology|1991|487

Structure-Based Design of Novel Potent Nonpeptide Thrombin Inhibitors

|Journal of Medicinal Chemistry|2002|454

Biophysics in drug discovery: impact, challenges and opportunities

|Nature Reviews Drug Discovery|2016|383

8-(3-(<i>R</i>)-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a Highly Potent, Selective, Long-Acting, and Orally Bioavailable DPP-4 Inhibitor for the Treatment of Type 2 Diabetes

|Journal of Medicinal Chemistry|2007|285